Brief: BVF Partners L.P. Says Closing Eli Lilly Deal Not In Favor Of Point Biopharma's Shareholders

POINT Biopharma Global

06/11/2023 19:02

Nov 6 (Reuters) - BVF Partners L.P.:
    * BVF PARTNERS L.P. REPORTS 16.5% STAKE IN POINT BIOPHARMA
GLOBAL
INC. AS OF NOVEMBER 2 - SEC FILING
    * BVF PARTNERS L.P.- PURCHASED POINT BIOPHARMA GLOBAL SHARES
BASED
ON BELIEF THAT SUCH SHARES, WHEN PURCHASED, WERE UNDERVALUED
    * BVF PARTNERS L.P.-WITHOUT SPLASH STUDY RESULTS, WILL NOT
TENDER
SHARES TO SUPPORT POINT BIOPHARMA GLOBAL, ELI LILLY DEAL IN
INITIAL TENDER PERIOD
    * BVF PARTNERS L.P- CLOSING ELI LILLY DEAL BEFORE POINT
BIOPHARMA
GLOBAL'S PHASE 3 SPLASH STUDY RESULTS NOT IN FAVOR OF POINT
BIOPHARMA'S SHAREHOLDERS


 ((Reuters.Briefs@thomsonreuters.com;))